found that reducing TSPAN7 expression on the cell surface by participating in the internalization process of the inhibitory neuronal DRD2 receptor is closely related to psychiatric disorders such as schizophrenia and is a target of antipsychotics commonly used in clinical practice (30). Here, TSPAN7 is linked to schizophrenia.